应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
HOOK Hookipa Pharma Inc
盘前交易 12-23 07:49:31 EST
2.02
-0.12
-5.61%
最高
2.14
最低
2.00
成交量
7.33万
今开
2.08
昨收
2.14
日振幅
6.54%
总市值
1,999万
流通市值
967.80万
总股本
989.50万
成交额
15.12万
换手率
1.53%
流通股本
479.11万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Hookipa Pharma Inc.盘中异动 早盘急速跳水6.54%
市场透视 · 12-20 23:08
Hookipa Pharma Inc.盘中异动 早盘急速跳水6.54%
Hookipa Pharma Inc.盘中异动 早盘股价大跌5.60%
市场透视 · 12-13
Hookipa Pharma Inc.盘中异动 早盘股价大跌5.60%
Hookipa Pharma Inc.股价上涨11.26% 市值涨335.27万美元
市场透视 · 12-12
Hookipa Pharma Inc.股价上涨11.26% 市值涨335.27万美元
Hookipa Pharma Inc.盘中异动 急速下挫5.08%
市场透视 · 12-03
Hookipa Pharma Inc.盘中异动 急速下挫5.08%
Hookipa Pharma Inc.盘中异动 早盘股价大涨6.00%报2.46美元
市场透视 · 11-28
Hookipa Pharma Inc.盘中异动 早盘股价大涨6.00%报2.46美元
Hookipa Pharma Inc.盘中异动 早盘大幅上涨5.03%
市场透视 · 11-26
Hookipa Pharma Inc.盘中异动 早盘大幅上涨5.03%
Hookipa Pharma Inc.盘中异动 股价大涨6.05%报2.28美元
市场透视 · 11-25
Hookipa Pharma Inc.盘中异动 股价大涨6.05%报2.28美元
Hookipa Pharma Inc.盘中异动 下午盘快速下挫5.65%
市场透视 · 11-23
Hookipa Pharma Inc.盘中异动 下午盘快速下挫5.65%
Hookipa Pharma Inc.2024财年第三财季实现净利润-13.84百万美元,同比增加27.43%
市场透视 · 11-23
Hookipa Pharma Inc.2024财年第三财季实现净利润-13.84百万美元,同比增加27.43%
Hookipa Pharma Inc.盘中异动 早盘急速下挫5.33%报2.84美元
市场透视 · 11-18
Hookipa Pharma Inc.盘中异动 早盘急速下挫5.33%报2.84美元
Hookipa Pharma Inc.盘中异动 下午盘大幅下挫5.29%
市场透视 · 11-14
Hookipa Pharma Inc.盘中异动 下午盘大幅下挫5.29%
HOOKIPA Pharma Inc 预计每股亏损 1.28 美元 - 财报前瞻
Reuters · 11-06
HOOKIPA Pharma Inc 预计每股亏损 1.28 美元 - 财报前瞻
Hookipa Pharma Inc.盘中异动 下午盘快速上涨6.10%报4.14美元
市场透视 · 10-18
Hookipa Pharma Inc.盘中异动 下午盘快速上涨6.10%报4.14美元
币安将移除HOOK/BTC、PDA/BTC现货交易对
金色财经 · 09-25
币安将移除HOOK/BTC、PDA/BTC现货交易对
Hookipa Pharma Inc.盘中异动 大幅跳水7.69%
市场透视 · 09-24
Hookipa Pharma Inc.盘中异动 大幅跳水7.69%
Hookipa Pharma Inc.2024财年第二财季实现净利润-19.10百万美元,同比减少5.99%
自选股智能写手 · 08-17
Hookipa Pharma Inc.2024财年第二财季实现净利润-19.10百万美元,同比减少5.99%
Hookipa Pharma Inc.盘中异动 股价大跌5.05%
自选股智能写手 · 08-15
Hookipa Pharma Inc.盘中异动 股价大跌5.05%
Hookipa Pharma Inc.盘中异动 股价大涨6.09%报4.70美元
自选股智能写手 · 08-13
Hookipa Pharma Inc.盘中异动 股价大涨6.09%报4.70美元
Hookipa Pharma Inc.盘中异动 股价大涨5.50%报5.18美元
自选股智能写手 · 08-08
Hookipa Pharma Inc.盘中异动 股价大涨5.50%报5.18美元
HOOKIPA Pharma Inc 预计每股亏损 1.25 美元 - 财报前瞻
Reuters · 08-06
HOOKIPA Pharma Inc 预计每股亏损 1.25 美元 - 财报前瞻
加载更多
公司概况
公司名称:
Hookipa Pharma Inc
所属市场:
NASDAQ
上市日期:
--
主营业务:
HOOKIPA Pharma Inc.于2017年2月根据特拉华州法律以Hookipa Biotech, Inc.的名义注册成立,是Hookipa Biotech AG的全资子公司。该公司是一家临床阶段的生物制药公司,开发基于专有沙粒病毒平台的新型免疫疗法,该平台旨在靶向和放大T细胞免疫反应以对抗疾病。该公司正在通过靶向癌病毒癌症抗原、自身抗原和下一代抗原,建立专有的免疫肿瘤学管道。该公司的肿瘤学产品组合包括三个已披露的项目,HB-200、HB-300和HB-700,它们都使用复制技术。
发行价格:
--
{"stockData":{"symbol":"HOOK","market":"US","secType":"STK","nameCN":"Hookipa Pharma Inc","latestPrice":2.02,"timestamp":1734728400000,"preClose":2.14,"halted":0,"volume":73274,"delay":0,"floatShares":4791100,"shares":9895000,"eps":-3.551078,"marketStatus":"盘前交易","marketStatusCode":1,"change":-0.12,"latestTime":"12-23 07:49:31 EST","open":2.08,"high":2.14,"low":2,"amount":151200.664523,"amplitude":0.065421,"askPrice":2.33,"askSize":100,"bidPrice":1.84,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-3.551078,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1734964200000},"adr":0,"listingDate":1555560000000,"adjPreClose":2.02,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":2.02,"preClose":2.02,"latestTime":"16:56 EST","volume":16,"amount":32.27,"timestamp":1734731781065},"volumeRatio":1.1368946976643537,"impliedVol":0.8792,"impliedVolPercentile":0.1968},"requestUrl":"/m/hq/s/HOOK","defaultTab":"news","newsList":[{"id":"2492870447","title":"Hookipa Pharma Inc.盘中异动 早盘急速跳水6.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492870447","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492870447?lang=zh_cn&edition=full","pubTime":"2024-12-20 23:08","pubTimestamp":1734707333,"startTime":"0","endTime":"0","summary":"北京时间2024年12月20日23时08分,Hookipa Pharma Inc.股票出现异动,股价大幅下挫6.54%。Hookipa Pharma Inc.股票所在的生物技术行业中,整体跌幅为0.35%。Hookipa Pharma Inc.公司简介:HOOKIPA Pharma Inc是一家临床阶段生物制药公司,基于其专有的鼻病毒平台开发了针对传染性疾病和癌症的一类免疫疗法,该平台旨在重编程机体的免疫系统。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220230853ab877647&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220230853ab877647&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","HOOK","BK4505"],"gpt_icon":0},{"id":"2491746653","title":"Hookipa Pharma Inc.盘中异动 早盘股价大跌5.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491746653","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491746653?lang=zh_cn&edition=full","pubTime":"2024-12-13 23:20","pubTimestamp":1734103206,"startTime":"0","endTime":"0","summary":"北京时间2024年12月13日23时20分,Hookipa Pharma Inc.股票出现异动,股价快速下挫5.60%。截至发稿,该股报2.02美元/股,成交量1.4627万股,换手率0.12%,振幅5.21%。Hookipa Pharma Inc.股票所在的生物技术行业中,整体跌幅为0.34%。Hookipa Pharma Inc.公司简介:HOOKIPA Pharma Inc是一家临床阶段生物制药公司,基于其专有的鼻病毒平台开发了针对传染性疾病和癌症的一类免疫疗法,该平台旨在重编程机体的免疫系统。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213232006984bd90c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213232006984bd90c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","HOOK"],"gpt_icon":0},{"id":"2490382968","title":"Hookipa Pharma Inc.股价上涨11.26% 市值涨335.27万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490382968","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490382968?lang=zh_cn&edition=full","pubTime":"2024-12-12 22:47","pubTimestamp":1734014823,"startTime":"0","endTime":"0","summary":"北京时间2024年12月12日22时47分,Hookipa Pharma Inc.股票出现波动,股价急速上涨11.26%。截至发稿,该股报2.47美元/股,成交量370股,换手率0.00%,振幅0.00%。Hookipa Pharma Inc.股票所在的生物技术行业中,整体跌幅为0.13%。Hookipa Pharma Inc.公司简介:HOOKIPA Pharma Inc是一家临床阶段生物制药公司,基于其专有的鼻病毒平台开发了针对传染性疾病和癌症的一类免疫疗法,该平台旨在重编程机体的免疫系统。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212224703a1e958e0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212224703a1e958e0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","HOOK","BK4505"],"gpt_icon":0},{"id":"2488570947","title":"Hookipa Pharma Inc.盘中异动 急速下挫5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488570947","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488570947?lang=zh_cn&edition=full","pubTime":"2024-12-03 23:46","pubTimestamp":1733240790,"startTime":"0","endTime":"0","summary":"北京时间2024年12月03日23时46分,Hookipa Pharma Inc.股票出现波动,股价快速下跌5.08%。截至发稿,该股报2.45美元/股,成交量1.0281万股,换手率0.09%,振幅3.41%。Hookipa Pharma Inc.股票所在的生物技术行业中,整体跌幅为0.48%。Hookipa Pharma Inc.公司简介:HOOKIPA Pharma Inc是一家临床阶段生物制药公司,基于其专有的鼻病毒平台开发了针对传染性疾病和癌症的一类免疫疗法,该平台旨在重编程机体的免疫系统。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203234630a269bbcb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203234630a269bbcb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","HOOK","BK4505"],"gpt_icon":0},{"id":"2486874842","title":"Hookipa Pharma Inc.盘中异动 早盘股价大涨6.00%报2.46美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486874842","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486874842?lang=zh_cn&edition=full","pubTime":"2024-11-28 00:28","pubTimestamp":1732724882,"startTime":"0","endTime":"0","summary":"北京时间2024年11月28日00时28分,Hookipa Pharma Inc.股票出现异动,股价急速拉升6.00%。截至发稿,该股报2.46美元/股,成交量1.5348万股,换手率0.13%,振幅3.84%。Hookipa Pharma Inc.股票所在的生物技术行业中,整体涨幅为0.42%。Hookipa Pharma Inc.公司简介:HOOKIPA Pharma Inc是一家临床阶段生物制药公司,基于其专有的鼻病毒平台开发了针对传染性疾病和癌症的一类免疫疗法,该平台旨在重编程机体的免疫系统。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241128002803971a8edd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241128002803971a8edd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HOOK","BK4139","BK4505"],"gpt_icon":0},{"id":"2486013760","title":"Hookipa Pharma Inc.盘中异动 早盘大幅上涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486013760","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486013760?lang=zh_cn&edition=full","pubTime":"2024-11-26 22:31","pubTimestamp":1732631474,"startTime":"0","endTime":"0","summary":"北京时间2024年11月26日22时31分,Hookipa Pharma Inc.股票出现波动,股价大幅上涨5.03%。Hookipa Pharma Inc.股票所在的生物技术行业中,整体涨幅为0.03%。Hookipa Pharma Inc.公司简介:HOOKIPA Pharma Inc是一家临床阶段生物制药公司,基于其专有的鼻病毒平台开发了针对传染性疾病和癌症的一类免疫疗法,该平台旨在重编程机体的免疫系统。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126223114a25744d2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126223114a25744d2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HOOK","BK4139","BK4505"],"gpt_icon":0},{"id":"2486803327","title":"Hookipa Pharma Inc.盘中异动 股价大涨6.05%报2.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486803327","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486803327?lang=zh_cn&edition=full","pubTime":"2024-11-25 22:47","pubTimestamp":1732546057,"startTime":"0","endTime":"0","summary":"北京时间2024年11月25日22时47分,Hookipa Pharma Inc.股票出现波动,股价急速拉升6.05%。Hookipa Pharma Inc.股票所在的生物技术行业中,整体涨幅为1.62%。Hookipa Pharma Inc.公司简介:HOOKIPA Pharma Inc是一家临床阶段生物制药公司,基于其专有的鼻病毒平台开发了针对传染性疾病和癌症的一类免疫疗法,该平台旨在重编程机体的免疫系统。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125224737abde02b2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125224737abde02b2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","HOOK","BK4139"],"gpt_icon":0},{"id":"2485130092","title":"Hookipa Pharma Inc.盘中异动 下午盘快速下挫5.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485130092","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485130092?lang=zh_cn&edition=full","pubTime":"2024-11-23 03:44","pubTimestamp":1732304688,"startTime":"0","endTime":"0","summary":"北京时间2024年11月23日03时44分,Hookipa Pharma Inc.股票出现波动,股价快速下挫5.65%。Hookipa Pharma Inc.股票所在的生物技术行业中,整体涨幅为0.49%。Hookipa Pharma Inc.公司简介:HOOKIPA Pharma Inc是一家临床阶段生物制药公司,基于其专有的鼻病毒平台开发了针对传染性疾病和癌症的一类免疫疗法,该平台旨在重编程机体的免疫系统。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112303444898e44396&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112303444898e44396&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","HOOK","BK4505"],"gpt_icon":0},{"id":"2485982702","title":"Hookipa Pharma Inc.2024财年第三财季实现净利润-13.84百万美元,同比增加27.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485982702","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485982702?lang=zh_cn&edition=full","pubTime":"2024-11-23 00:03","pubTimestamp":1732291407,"startTime":"0","endTime":"0","summary":"11月23日,Hookipa Pharma Inc.公布财报,公告显示公司2024财年第三财季净利润为-13.84百万美元,同比增加27.43%;其中营业收入为4.70百万美元,同比减少31.59%,每股基本收益为-1.10美元。从资产负债表来看,Hookipa Pharma Inc.总负债37.93百万美元,其中短期债务1.21百万美元,资产负债比为0.03,流动比率为3.27。机构评级:截至2024年11月23日,当前有4家机构对Hookipa Pharma Inc.目标价做出预测,其中目标均价为36.25美元,其中最低目标价为7.00美元,最高目标价为50.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123000359abd7b980&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123000359abd7b980&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HOOK"],"gpt_icon":0},{"id":"2484467742","title":"Hookipa Pharma Inc.盘中异动 早盘急速下挫5.33%报2.84美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484467742","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484467742?lang=zh_cn&edition=full","pubTime":"2024-11-18 23:58","pubTimestamp":1731945519,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日23时58分,Hookipa Pharma Inc.股票出现波动,股价急速跳水5.33%。截至发稿,该股报2.84美元/股,成交量1.7527万股,换手率0.15%,振幅5.33%。Hookipa Pharma Inc.股票所在的生物技术行业中,整体涨幅为0.02%。Hookipa Pharma Inc.公司简介:HOOKIPA Pharma Inc是一家临床阶段生物制药公司,基于其专有的鼻病毒平台开发了针对传染性疾病和癌症的一类免疫疗法,该平台旨在重编程机体的免疫系统。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118235839a2435182&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118235839a2435182&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HOOK","BK4139","BK4505"],"gpt_icon":0},{"id":"2483854675","title":"Hookipa Pharma Inc.盘中异动 下午盘大幅下挫5.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483854675","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483854675?lang=zh_cn&edition=full","pubTime":"2024-11-14 03:33","pubTimestamp":1731526435,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日03时33分,Hookipa Pharma Inc.股票出现异动,股价快速下挫5.29%。Hookipa Pharma Inc.股票所在的生物技术行业中,整体跌幅为0.43%。Hookipa Pharma Inc.公司简介:HOOKIPA Pharma Inc是一家临床阶段生物制药公司,基于其专有的鼻病毒平台开发了针对传染性疾病和癌症的一类免疫疗法,该平台旨在重编程机体的免疫系统。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114033355971a65cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114033355971a65cf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HOOK","BK4139","BK4505"],"gpt_icon":0},{"id":"2481607919","title":"HOOKIPA Pharma Inc 预计每股亏损 1.28 美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2481607919","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481607919?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:13","pubTimestamp":1730902396,"startTime":"0","endTime":"0","summary":" * HOOKIPA Pharma Inc 预计将在11月7日公布截至2024年9月30日的业绩(估计),季度收入将出现下降。* 根据LSEG的数据,2位分析师的平均预期显示,这家总部位于纽约的公司的营收预计将从去年同期的687万美元下降9.0%,至625万美元。* LSEG 的分析师平均预计 HOOKIPA Pharma Inc 每股亏损 1.28 美元。* 华尔街对 HOOKIPA Pharma Inc 的 12 个月目标价中位数为 50.00 美元,高于其上一次收盘价 3.81 美元。11月6日 - 上一季度业绩。除非另有说明,否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"HOOKIPA Pharma Inc 预计每股亏损 1.28 美元 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HOOK"],"gpt_icon":0},{"id":"2476489461","title":"Hookipa Pharma Inc.盘中异动 下午盘快速上涨6.10%报4.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2476489461","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476489461?lang=zh_cn&edition=full","pubTime":"2024-10-18 02:06","pubTimestamp":1729188411,"startTime":"0","endTime":"0","summary":"北京时间2024年10月18日02时06分,Hookipa Pharma Inc.股票出现异动,股价快速上涨6.10%。截至发稿,该股报4.14美元/股,成交量8614股,换手率0.09%,振幅4.87%。Hookipa Pharma Inc.股票所在的生物技术行业中,整体涨幅为1.00%。Hookipa Pharma Inc.公司简介:HOOKIPA Pharma Inc是一家临床阶段生物制药公司,基于其专有的鼻病毒平台开发了针对传染性疾病和癌症的一类免疫疗法,该平台旨在重编程机体的免疫系统。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241018020651a1e1711c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241018020651a1e1711c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HOOK","BK4139","BK4505"],"gpt_icon":0},{"id":"2470285212","title":"币安将移除HOOK/BTC、PDA/BTC现货交易对","url":"https://stock-news.laohu8.com/highlight/detail?id=2470285212","media":"金色财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470285212?lang=zh_cn&edition=full","pubTime":"2024-09-25 15:05","pubTimestamp":1727247940,"startTime":"0","endTime":"0","summary":null,"market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.jinse.com/noah/v2/lives","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinse_live","symbols":["BTC","BTCmain","HOOK","BK4139","BK4505","BTC.USD.HKCC","XBTmain"],"gpt_icon":0},{"id":"2469124723","title":"Hookipa Pharma Inc.盘中异动 大幅跳水7.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2469124723","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469124723?lang=zh_cn&edition=full","pubTime":"2024-09-24 03:39","pubTimestamp":1727120377,"startTime":"0","endTime":"0","summary":"北京时间2024年09月24日03时39分,Hookipa Pharma Inc.股票出现波动,股价快速跳水7.69%。Hookipa Pharma Inc.股票所在的生物技术行业中,整体跌幅为2.73%。Hookipa Pharma Inc.公司简介:HOOKIPA Pharma Inc是一家临床阶段生物制药公司,基于其专有的鼻病毒平台开发了针对传染性疾病和癌症的一类免疫疗法,该平台旨在重编程机体的免疫系统。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240924033937a1dbf702&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240924033937a1dbf702&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","HOOK","BK4505"],"gpt_icon":0},{"id":"2460499742","title":"Hookipa Pharma Inc.2024财年第二财季实现净利润-19.10百万美元,同比减少5.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460499742","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460499742?lang=zh_cn&edition=full","pubTime":"2024-08-17 00:00","pubTimestamp":1723824036,"startTime":"0","endTime":"0","summary":"8月17日,Hookipa Pharma Inc.公布财报,公告显示公司2024财年第二财季净利润为-19.10百万美元,同比减少5.99%;其中营业收入为1.29百万美元,同比减少51.87%,每股基本收益为-1.52美元。从资产负债表来看,Hookipa Pharma Inc.总负债38.98百万美元,其中短期债务1.51百万美元,资产负债比为0.04,流动比率为0.04。机构评级:截至2024年8月17日,当前有5家机构对Hookipa Pharma Inc.目标价做出预测,其中目标均价为39.80美元,其中最低目标价为15.00美元,最高目标价为60.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408170005579f31b11d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408170005579f31b11d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HOOK"],"gpt_icon":0},{"id":"2459007771","title":"Hookipa Pharma Inc.盘中异动 股价大跌5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459007771","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459007771?lang=zh_cn&edition=full","pubTime":"2024-08-15 01:06","pubTimestamp":1723655187,"startTime":"0","endTime":"0","summary":"北京时间2024年08月15日01时06分,Hookipa Pharma Inc.股票出现波动,股价快速下跌5.05%。Hookipa Pharma Inc.股票所在的生物技术行业中,整体跌幅为0.46%。Hookipa Pharma Inc.公司简介:HOOKIPA Pharma Inc是一家临床阶段生物制药公司,基于其专有的鼻病毒平台开发了针对传染性疾病和癌症的一类免疫疗法,该平台旨在重编程机体的免疫系统。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081501062797198bed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081501062797198bed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HOOK","BK4139","BK4505"],"gpt_icon":0},{"id":"2459904023","title":"Hookipa Pharma Inc.盘中异动 股价大涨6.09%报4.70美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459904023","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459904023?lang=zh_cn&edition=full","pubTime":"2024-08-13 22:09","pubTimestamp":1723558142,"startTime":"0","endTime":"0","summary":"北京时间2024年08月13日22时09分,Hookipa Pharma Inc.股票出现异动,股价急速拉升6.09%。截至发稿,该股报4.70美元/股,成交量2285股,换手率0.02%,振幅4.06%。Hookipa Pharma Inc.股票所在的生物技术行业中,整体涨幅为1.32%。Hookipa Pharma Inc.公司简介:HOOKIPA Pharma Inc是一家临床阶段生物制药公司,基于其专有的鼻病毒平台开发了针对传染性疾病和癌症的一类免疫疗法,该平台旨在重编程机体的免疫系统。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081322090298e34de7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081322090298e34de7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","HOOK"],"gpt_icon":0},{"id":"2457345267","title":"Hookipa Pharma Inc.盘中异动 股价大涨5.50%报5.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457345267","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457345267?lang=zh_cn&edition=full","pubTime":"2024-08-08 23:33","pubTimestamp":1723131208,"startTime":"0","endTime":"0","summary":"北京时间2024年08月08日23时33分,Hookipa Pharma Inc.股票出现波动,股价快速上涨5.50%。截至发稿,该股报5.18美元/股,成交量1.4296万股,换手率0.15%,振幅6.29%。Hookipa Pharma Inc.股票所在的生物技术行业中,整体涨幅为2.65%。Hookipa Pharma Inc.公司简介:HOOKIPA Pharma Inc是一家临床阶段生物制药公司,基于其专有的鼻病毒平台开发了针对传染性疾病和癌症的一类免疫疗法,该平台旨在重编程机体的免疫系统。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080823332896825367&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080823332896825367&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HOOK","BK4139","BK4505"],"gpt_icon":0},{"id":"2457222180","title":"HOOKIPA Pharma Inc 预计每股亏损 1.25 美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2457222180","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457222180?lang=zh_cn&edition=full","pubTime":"2024-08-06 23:24","pubTimestamp":1722957854,"startTime":"0","endTime":"0","summary":" * HOOKIPA Pharma Inc 将于8月8日公布截至2024年6月30日的财报(估计),预计季度收入将有所增长。* 根据LSEG的数据,4位分析师的平均预期显示,这家总部位于纽约的公司的营收预计将从去年同期的268万美元增长164.7%,达到709.1万美元。* LSEG 的分析师平均预计 HOOKIPA Pharma Inc 每股亏损 1.25 美元。* 华尔街对 HOOKIPA Pharma Inc 的 12 个月目标价中位数为 45.00 美元,高于其上次收盘价 4.67 美元。8月6日 - 上一季度业绩。除非另有说明,否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"HOOKIPA Pharma Inc 预计每股亏损 1.25 美元 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HOOK"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.hookipapharma.com","stockEarnings":[{"period":"1week","weight":-0.0516},{"period":"1month","weight":-0.2574},{"period":"3month","weight":-0.5738},{"period":"6month","weight":-0.6868},{"period":"1year","weight":-0.7658},{"period":"ytd","weight":-0.7506}],"compareEarnings":[{"period":"1week","weight":-0.0221},{"period":"1month","weight":0.0006},{"period":"3month","weight":0.0397},{"period":"6month","weight":0.0851},{"period":"1year","weight":0.2499},{"period":"ytd","weight":0.243}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"HOOKIPA Pharma Inc.于2017年2月根据特拉华州法律以Hookipa Biotech, Inc.的名义注册成立,是Hookipa Biotech AG的全资子公司。该公司是一家临床阶段的生物制药公司,开发基于专有沙粒病毒平台的新型免疫疗法,该平台旨在靶向和放大T细胞免疫反应以对抗疾病。该公司正在通过靶向癌病毒癌症抗原、自身抗原和下一代抗原,建立专有的免疫肿瘤学管道。该公司的肿瘤学产品组合包括三个已披露的项目,HB-200、HB-300和HB-700,它们都使用复制技术。","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":-0.081948},{"month":2,"riseRate":0.6,"avgChangeRate":0.127152},{"month":3,"riseRate":0.2,"avgChangeRate":-0.060883},{"month":4,"riseRate":0.8,"avgChangeRate":0.068686},{"month":5,"riseRate":0.666667,"avgChangeRate":0.071254},{"month":6,"riseRate":0.166667,"avgChangeRate":-0.206156},{"month":7,"riseRate":0.166667,"avgChangeRate":-0.086653},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.03502},{"month":9,"riseRate":0.166667,"avgChangeRate":-0.08921},{"month":10,"riseRate":0.166667,"avgChangeRate":-0.090753},{"month":11,"riseRate":0.5,"avgChangeRate":-0.010505},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.020604}],"exchange":"NASDAQ","name":"Hookipa Pharma Inc","nameEN":"Hookipa Pharma Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Hookipa Pharma Inc(HOOK)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Hookipa Pharma Inc(HOOK)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Hookipa Pharma Inc,HOOK,Hookipa Pharma Inc股票,Hookipa Pharma Inc股票老虎,Hookipa Pharma Inc股票老虎国际,Hookipa Pharma Inc行情,Hookipa Pharma Inc股票行情,Hookipa Pharma Inc股价,Hookipa Pharma Inc股市,Hookipa Pharma Inc股票价格,Hookipa Pharma Inc股票交易,Hookipa Pharma Inc股票购买,Hookipa Pharma Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Hookipa Pharma Inc(HOOK)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Hookipa Pharma Inc(HOOK)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}